Safety aspects of gonadotrophin-releasing hormone antagonists in ovarian stimulation procedures: ovarian hyperstimulation syndrome and health of children born. (Q35049452)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Safety aspects of gonadotrophin-releasing hormone antagonists in ovarian stimulation procedures: ovarian hyperstimulation syndrome and health of children born.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12537784%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

0 references

1 reference

Europe PubMed Central

Safety aspects of gonadotrophin-releasing hormone antagonists in ovarian stimulation procedures: ovarian hyperstimulation syndrome and health of children born (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12537784%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

ovarian hyperstimulation syndrome

1 reference

based on heuristic

inferred from title

author name string

M Ludwig

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12537784%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

A Katalinic

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12537784%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

R E Felberbaum

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12537784%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

K Diedrich

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12537784%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12537784%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Reproductive BioMedicine Online

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12537784%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

5 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12537784%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

61-67

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12537784%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A fatal case of ovarian hyperstimulation syndrome with cerebral infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix).

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Accidental exposure to daily long-acting gonadotrophin-releasing hormone analogue administration and pregnancy in an in-vitro fertilization cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Pregnancy during long-term gonadotropin-releasing hormone agonist therapy associated with clinical pseudomenopause

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired corpus luteum function and other undesired results of pregnancies associated with inadvertent administration of a long-acting agonist of gonadotrophin-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of children born after inadvertent administration of a gonadotrophin-releasing hormone agonist in early pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Deep vein thrombosis during administration of HMG for ovarian stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Perinatal outcome of pregnancy after GnRH antagonist (ganirelix) treatment during ovarian stimulation for conventional IVF or ICSI: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of cryopreservation outcome with gonadotropin-releasing hormone agonists or antagonists in the collecting cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960219-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1472-6483(11)60219-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12537784%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12537784%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35049452&oldid=1528045854"